Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on NEKTAN PLC. We currently have 17 research reports from 5 professional analysts.
|15Mar17 07:00||RNS||Respin LLC signs first major contract|
|23Feb17 07:00||RNS||Directorate Change|
|06Feb17 07:00||RNS||INCREASED OWNERSHIP OF RESPIN US JV TO 100%|
|03Feb17 07:00||RNS||Holding(s) in Company|
|27Jan17 11:41||RNS||Results of AGM and Offer for Subscription|
|16Jan17 07:12||RNS||Appointment of New Chief Financial Officer|
|16Jan17 07:10||RNS||Appointment of Stockdale Securities|
Frequency of research reports
Research reports on
Small Cap Breakfast
29 Mar 17
Path Investments—Publication of prospectus from the Energy Investment Company. Raising £1.4m. Admission due on or around 30 March | Franchise Brands—Schedule 1 detailing £28m reverse takeover of Metro Rod. Admission expected 11 April | Alpha FX Group— Schedule 1 from the foreign exchange provider focused on managing exchange rate risk for UK corporates that trade internationally. Fundraise TBC. Admission expected 7 April | SkinBioTherapeutics—Schedule 1 update from the Company focused on certain molecules found in the human microbiota that can be used to protect, manage and restore the skin. £4.5m raise. Admission due 5 April | Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April | Tufton Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.
Small Cap Breakfast
09 Jan 17
Arian Silver Corp (AGQ.L) | Eco Animal Health (EAH.L) | Panmure Gordon & Co (PMR.L) | E K F Diagnostics Holdings (EKF.L) | Keras Resources (KRS.L) | Restore PLC (RST.L) | boohoo.com (BOO.L) | Premier Technical Services Group (PTSG.L) | Space and People (SAL.L) | Nektan (NKTN.L)
01 Jul 16
Nektan today announces a pre-close trading update for the year ended 30 June 2016. Total net gaming revenue (NGR) increase by 160% over H116 to £4.2m, with player numbers similarly up, with total cash bets increasing by 129% to £104.1m versus £45.4m in H116. The number of first time depositors also increased by 77% to 30,997. While Nektan launched 29 new partners in to its network over the year, the migration of customer partners to the new Evolve 2 platform during Q416 caused some slowdown in growth due to downtime and testing of the new platform, and as a result, EBITDA is marginally below expectations. This is now fully operational and functional.
Respin JV receives approval for release of Class II Mobile Solution product
14 Jun 16
Nektan’s JV in the US, Respin, has received approval from the designated and independent test lab for release of its “Rapid Games” product, a Class II Mobile in-venue gaming solution. Class II compliance certification opens the way for tribal jurisdictions to start deploying this product, which will allow players to play Class II games on their own mobile device, within designated areas of casino property .
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)
Small Cap Breakfast
28 Mar 17
Path Investments—Publication of prospectus from the Energy Investment Company. Raising £1.4m. Admission due on or around 30 March | Franchise Brands—Schedule 1 detailing £28m reverse takeover of Metro Rod. Admission expected 11 April | Alpha FX Group— Schedule 1 from the foreign exchange provider focused on managing exchange rate risk for UK corporates that trade internationally. Fundraise TBC. Admission expected 7 April. | K3 | Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. | Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Tufton | Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.
Strong set of full-year results, comforting guidance
23 Mar 17
GVC released a solid set of full-year results. Key highlights Pro forma Net Gaming Revenue (NGR) was up 12% at constant currency, or 9% on a reported basis at €895m, in line with the February trading update. Pro forma clean EBITDA was up 26%, at €205.7m, bang in line with AV’s €206m forecasts, translating a three percentage points increase in margin added to the growth in revenue. c.69% of NGR was derived from markets either regulated (including those in the process of regulating) and/or locally taxed (68% in 2015), while 95% of the revenues were derived from GVC’s proprietary platform. Net debt stood at €131.5m or 0.6x clean EBITDA. The board proposed a second special dividend of €0.15, giving a total dividend of €0.30 per share for the year, beating market expectations. Guidance The start of 2017 seems promising as management said that daily NGR had increased by 15% (+16% cc), translating into an 18% (+19% cc) growth in sports labels’ daily NGR and a 6% (+8% cc) increase in games labels’ daily NGR. The gross win margin reached 9.5% while it should move towards the 10% mark on the long term. Regarding dividends, the group confirmed a progressive distribution policy and expects to distribute at least 50% of the group’s free cash flow, starting from 2017. Debt refinancing In the first quarter of 2017, the group issued a €320m Senior Secured Term and Revolving Facility, composed of a €250m term loan (maturity 6 years) and a €70m revolving credit facility (maturity 5 years) used to pay down the Nomura Loan in full.
Driven by distribution
24 Mar 17
Following results earlier this month, we publish our new forecasts following the segmental consolidation of divisions, and remain cautious relative to consensus (c.2% below at the PBT level in FY18E) mainly due to our UK assumptions. We believe the valuation is relatively attractive, and Inchcape is well placed for further growth given the strength of its balance sheet as it seeks to further utilise its unique global market position.
Another record performance in FY16 underpins estimates
23 Mar 17
January’s pre-close trading statement had already stated that the FY16 revenue outcome was a record £163.1m (FY15: £148.9m) and indicated that profitability was in line with consensus expectations of £20.4m. The actual outcome of £20.5m is c. 2% ahead of ZC estimate of £20.2m. Organic FY16 revenue and profit growth of c. 10% and c.14% respectively is impressive in the context of an RMI market that was broadly flat during the year. This reflects Safestyle’s competitive advantage allowing it to take market share. We remain concerned with current headwinds across the wider building products sector, including input cost inflation, the UK consumer and the general economic outlook, but believe Safestyle is better placed to deal with these than most and will continue to drive organic growth in FY17. Cash adjusted, the shares trade on just 12.7x FY17 earnings with the potential for further special dividends in the coming years post completion of the recent capex program relating to the new production facility.